Home > Financial Ratios > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

BALAXI PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -23.46-24.787.6324.25407.44

What is the latest Core EBITDA Growth ratio of BALAXI PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of BALAXI PHARMACEUTICALS is -23.46 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025-23.46
Mar2024-24.78
Mar20237.63
Mar202224.25
Mar2021407.44

How is Core EBITDA Growth of BALAXI PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 -23.46
Negative
Mar2024 -24.78
Negative
Mar2023 7.63
-68.54
Mar2022 24.25
-94.05
Mar2021 407.44 -

Other Financial Ratios of BALAXI PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of BALAXI PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS ₹97.4 Cr -0.1% -13.4% -73.8% Stock Analytics
ADANI ENTERPRISES ₹249,145.0 Cr -2.4% -12.8% -11.3% Stock Analytics
REDINGTON ₹16,988.0 Cr -6.7% -16% -2.8% Stock Analytics
HONASA CONSUMER ₹9,414.6 Cr 8.6% -4.1% 33.2% Stock Analytics
MMTC ₹8,964.0 Cr 13.8% -5.9% 22.1% Stock Analytics
LLOYDS ENTERPRISES ₹6,910.7 Cr -1.2% -22.9% 32.1% Stock Analytics


BALAXI PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS

-0.1%

-13.4%

-73.8%

SENSEX

-0%

-10.7%

1%


You may also like the below Video Courses